



Miebach Consulting has launched an international survey in order to evaluate the most relevant challenges and trends for supply chain organizations within the pharma & life sciences industry.

Last year, Rentschler Biopharma, a German contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced its "Strategy 2025."




Outsourcing product development and manufacturing has become for many pharmaceutical and biotech companies a strategic activity and an integral part of their business model.
















The pharmaceutical industry continues to grow and is estimated to be worth $1.5 trillion by 2021.










